+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The chemotherapy of rodent malaria, XXV. Antimalarial activity of WR 122,455 (a 9-phenanthrenemethanol) in vivo and in vitro



The chemotherapy of rodent malaria, XXV. Antimalarial activity of WR 122,455 (a 9-phenanthrenemethanol) in vivo and in vitro



Annals of Tropical Medicine and Parasitology 70(3): 259-270



WR 122,455, 3,6-bis-(trifluoromethyl)-alpha-(2-piperidinyl)-9-phenanthrenemethanol HCl, suppresses infection with drug-sensitive Plasmodium berghei N strain in mice. It acts rapidly and affects all the stages of the asexual intraerythrocytic parasites, the effective dose levels being about three times those of chloroquine and one-twelfth to one-fifteenth those of quinine. Under the influence of WR 122,455 haemozoin seems to disappear from the affected parasites following an initial coarsening of the fine pigment granules. These changes are similar to those exerted by quinine. Large doses of WR 122,455 have a residual affect due in part, at least, to deposition of insoluble material in the tissues. The drug appears to exert an antagonistic action on chloroquine when both drugs are administered simultaneously. It has no causal prophylactic effect. In vitro WR 122,455 is a competitive antagonist of chloroquine in a similar manner to quinine, and appears to have a dissociation constant (Ki) of 2-26 x 10(-8) M, making it about 18 times as active as quinine. WR 122,455 interacts strongly with calf thymus DNA, but the mechanism of interaction has yet to be defined. Mice tolerate single doses of a saline/Tween 80 suspensions up to about 400 mg/kg but sc administration induces necrotic changes at the injection site. Up to 30 mg/kg daily po for seven consecutive days is well tolerated systemically but local tissue reaction may occur if the drug is given by the sc or ip routes. However, systemically up to 60 mg/kg is tolerated sc or ip. The relation of WR 122,455 to drug resistant malaria will be reported later.

(PDF emailed within 1 workday: $29.90)

Accession: 041590053

Download citation: RISBibTeXText

PMID: 788657


Related references

The chemotherapy of rodent malaria, XXVI. The potential value of WR 122,455 (a 9-phenanthrenemethanol) against drug-resistant malaria parasites. Annals of Tropical Medicine and Parasitology 70(3): 271-281, 1976

The chemotherapy of rodent malaria, XXI. Action of quinine and WR 122 (a 9-phenanthrenemethanol) on the fine structure of Plasmodium berghei in mouse blood. Annals of Tropical Medicine and Parasitology 69(2): 147-153, 1975

The chemotherapy of rodent malaria, XXXVIII. Studies on the activity of three new antimalarials (WR 194,965, WR 228,258 and WR 225,448) against rodent and human malaria parasites (Plasmodium berghei and P. falciparum). Annals of Tropical Medicine and Parasitology 78(6): 567-579, 1984

Comparison of in vivo and in vitro antimalarial activity of artemisinin, dihydroartemisinin and sodium artesunate in the Plasmodium berghei-rodent model. International Journal for Parasitology 24(4): 589-594, 1994

Evaluation of the antimalarial activity of the phenanthrenemethanol halofantrine.. American Journal of Tropical Medicine and Hygiene 32(4): 908-909, 1983

Evaluation of the antimalarial activity of the phenanthrenemethanol halofantrine (WR 171,669). American Journal of Tropical Medicine and Hygiene 31(6): 1075-1079, 1982

Ex Vivo Maturation Assay for Testing Antimalarial Sensitivity of Rodent Malaria Parasites. Antimicrobial Agents and ChemoTherapy 60(11): 6859-6866, 2016

Antimalarial activity and conformation of erythro- and threo- -(2-piperidyl)-3,6-bis(trifluoromethyl)-9-phenanthrenemethanol. Journal of Medicinal Chemistry 15(2): 207-208, 1972

Preparation and antimalarial activity of some derivatives of 6-bromo-alpha-(di-n-heptylaminomethyl)-9-phenanthrenemethanol. Journal of Medicinal Chemistry 16(8): 940-942, 1973

Synthesis, Docking, In Vitro and In Vivo Antimalarial Activity of Hybrid 4-aminoquinoline-1,3,5-triazine Derivatives Against Wild and Mutant Malaria Parasites. Chemical Biology and Drug Design 86(3): 265-271, 2016

The antimalarial activity of N-benzyloxydihydrotriazines. I. The activity of clociquanil (BRI 50216) against rodent malaria, and studies on its mode of action. Annals of Tropical Medicine and Parasitology 74(4): 393-404, 1980

The chemo therapy of rodent malaria part 21 action of quinine and wr 122455 a 9 phenanthrenemethanol on the fine structure of plasmodium berghei in mouse blood. Annals of Tropical Medicine & Parasitology 69(2): 147-154, 1975

Toward a novel metal-based chemotherapy against tropical diseases. 2. Synthesis and antimalarial activity in vitro and in vivo of new ruthenium- and rhodium-chloroquine complexes. Journal of Medicinal Chemistry 39(5): 1095-1099, 1996

Toward a novel metal-based chemotherapy against tropical diseases. 3. Synthesis and antimalarial activity in vitro and in vivo of the new gold-chloroquine complex [Au(PPh3)(CQ)]PF6. Journal of Medicinal Chemistry 40(12): 1937-1939, 1997

In vitro and in vivo antimalarial activity of ferrochloroquine, a ferrocenyl analogue of chloroquine against chloroquine-resistant malaria parasites. Parasitology Research 87(3): 239-244, 2001